These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10369864

  • 1. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.
    Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH.
    Hum Mol Genet; 1999 Jul; 8(7):1195-9. PubMed ID: 10369864
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A linkage study of cytotoxic T lymphocyte-associated antigen 4 gene and Graves' disease in northern Chinese Han ethnic].
    Jin Y, Ben S, Teng W, Zhang J, Xiong X, Zhao Y, Huang W.
    Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):809-12. PubMed ID: 12654233
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
    Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, Kendall-Taylor P, Pearce SH.
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
    [Abstract] [Full Text] [Related]

  • 7. The genetics of Graves' disease.
    Gough SC.
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):255-66. PubMed ID: 10874528
    [Abstract] [Full Text] [Related]

  • 8. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
    Kouki T, Gardine CA, Yanagawa T, Degroot LJ.
    J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
    Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M, Ayadi H.
    Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry.
    Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA.
    Hum Mol Genet; 1996 Jul; 5(7):1075-80. PubMed ID: 8817351
    [Abstract] [Full Text] [Related]

  • 14. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.
    Heward JM, Allahabadia A, Carr-Smith J, Daykin J, Cockram CS, Gordon C, Barnett AH, Franklyn JA, Gough SC.
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):331-4. PubMed ID: 9861324
    [Abstract] [Full Text] [Related]

  • 15. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
    Zaletel K, Krhin B, Gaberscek S, Pirnat E, Hojker S.
    Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
    [Abstract] [Full Text] [Related]

  • 16. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study.
    Holopainen P, Arvas M, Sistonen P, Mustalahti K, Collin P, Mäki M, Partanen J.
    Tissue Antigens; 1999 May; 53(5):470-5. PubMed ID: 10372542
    [Abstract] [Full Text] [Related]

  • 17. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF.
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
    Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ.
    J Immunol; 2000 Dec 01; 165(11):6606-11. PubMed ID: 11086105
    [Abstract] [Full Text] [Related]

  • 20. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
    Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K.
    Tissue Antigens; 1998 May 01; 51(5):563-6. PubMed ID: 9672157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.